We are pleased to announce the publication of the article, “Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non–Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT),” now available in JCO Global Oncology.
A Dra. Janine Capobiango Martins, membro da comissão organizadora, convida você para participar do IV Simpósio LACOG de Oncogeriatria.
Nesta edição, o simpósio será realizado no dia 14 de agosto, no Hotel InterContinental, em São Paulo.
https://t.co/8hgOfVpQIv
#LACOG
Nesta última semana recebemos a equipe da DRS em nosso escritório para um encontro de trocas.
Encontros como esse reforçam a importância do diálogo e da construção conjunta de soluções que contribuam para o desenvolvimento da pesquisa clínica e da saúde na América Latina.
#LACOG
A Dra. Ludmila Koch, membro da comissão organizadora, convida você para participar do IV Simpósio LACOG de Oncogeriatria.
A edição de 2026 será realizada em 14 de agosto, no Hotel InterContinental, em São Paulo.
Acesse e inscreva-se:
https://t.co/8hgOfVpQIv
On May 31, at ASCO 2026, Dr. Débora Gagliato moderated the Metastatic Breast Cancer session, where Dr. Carlos Barrios, President of LACOG, presented the ASCENT-03 study. Their participation highlights Latin American leadership in global oncology discussions.
#LACOG#ASCO2026
We are excited to announce the new members of the Brazil and LATAM board of the LACOG Gastrointestinal Group.
The board will serve from 2026 to 2028, with a primary focus on developing clinical and epidemiological studies.
#LACOG#CancerResearch
The LACOG Office Team proudly attended ASCO 2026 in Chicago, engaging with global partners, advancing ongoing studies, and shaping future research initiatives. Together, we're strengthening collaborations and expanding research opportunities across Latin America.
#LACOG
Dra. Andrea Shimada, membro da comissão organizadora, convida você para participar do IV Simpósio LACOG de Oncogeriatria. A edição de 2026 será realizada no dia 14 de Agosto, no Hotel InterContinental, em São Paulo.
Acesse e inscreva-se:
https://t.co/8hgOfVpQIv
Participe da IV edição do Simpósio LACOG de Oncogeriatria!
O evento será realizado no Hotel InterContinental, no dia 14 de agosto de 2026, em São Paulo (SP). Não perca a oportunidade de se atualizar e aprofundar seus conhecimentos na área.
https://t.co/8hgOfVpQIv
O IV Simpósio LACOG de Oncogeriatria já tem data marcada!
O encontro acontecerá no dia 14 de agosto de 2026, no Hotel InterContinental, SP, reunindo importantes especialistas para discutir os avanços mais relevantes no cuidado ao paciente idoso com câncer.
https://t.co/8hgOfVpQIv
At ASCO 2026, leaders of the NoLEEta study discuss the rationale and potential impact of this international Phase III trial evaluating a chemotherapy-free strategy for patients with intermediate-risk HR+/HER2− early breast cancer. Watch the full video.
#ASCO2026#LACOG#NoLEEta
At ASCO 2026, the NoLEEta study was presented as a poster.
This international Phase III trial, conducted with Unicancer, evaluates whether ribociclib plus endocrine therapy can replace adjuvant chemotherapy in intermediate-risk HR+/HER2− early breast cancer.
#ASCO2026#LACOG
At ASCO 2026, the OMEGA study, a collaboration between LACOG and GBOT, was featured in an educational presentation.
The study explores oncologists’ perspectives on liquid biopsy (ctDNA) in NSCLC, reinforcing the relevance of molecular testing in oncology.
#LACOG#GBOT
At ASCO 2026, the OMEGA study was highlighted in an educational session.
Developed by LACOG and GBOT, the study evaluates oncologists’ perspectives on the use of liquid biopsy (ctDNA) in NSCLC, emphasizing the growing importance of molecular testing in oncology.
#LACOG#GBOT
At ASCO 2026, Dr. Gisah Guilgen presented the ASTRAL Survey (LACOG 1123).
The findings revealed high willingness among Brazilian breast cancer patients to participate in clinical trials and highlighted opportunities to improve education and access to clinical research in Brazil.
At ASCO 2026, Dr. Giuliano Borges presented the GUIDE-Breast Survey, developed by LACOG and GBECAM.
The findings highlight the widespread use of clinical guidelines among Brazilian breast oncologists, helping ensure high-quality cancer care.
#LACOG#GBECAM